줄기세포 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 기술별, 치료법별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)
Stem Cell Market Size, Share, Growth Analysis, By Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs)), By Application (Regenerative Medicine), By Technology, By Therapy, By End-Use and By Region - Industry Forecast 2024-2031
상품코드:1619094
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 275 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 줄기세포 시장 규모는 2022년 119억 달러로 평가되며, 2023년 133억 달러에서 2031년 316억 달러로 성장하여 예측 기간(2024-2031년) 동안 11.4%의 CAGR로 성장할 것으로 예상됩니다.
세계 줄기세포 시장은 세계 임상시험의 증가와 혁신적인 치료법의 채택에 힘입어 상당한 성장이 예상되며, COVID-19 팬데믹으로 인해 줄기세포 치료에 대한 관심이 높아져 면역 조절 치료에 대한 적용이 유망하고 현재 진행 중인 연구가 진행되고 있습니다. 이러한 치료법에 대한 접근성을 강화하기 위한 Cellino Biotech의 8,000만 달러의 자금 조달로 대표되는 대규모 투자는 상업적 발전의 가능성을 보여줍니다. 호주의 혁신적인 줄기세포 프로젝트에 대한 590만 달러의 자금 지원과 같은 정부 이니셔티브는 시장 확대를 더욱 촉진하고 있습니다. 그러나 높은 비용과 윤리적 딜레마 등 여전히 해결해야 할 과제도 남아있습니다. 이러한 장애물에도 불구하고 재생의료에 대한 수요 증가와 지속적인 연구 노력은 줄기세포 부문의 성장과 기회에 대한 유망한 전망을 제시하여 기업과 환자 모두에게 이익을 가져다 줄 것입니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석과 영향
경쟁 기업 간의 경쟁 관계
대체품의 위협
구매자의 교섭력
신규 참여업체의 위협
공급 기업의 교섭력
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
생태계 매핑
시장 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
기술 평가
규제 상황
고객과 구매 기준 분석
파이프라인 분석
질병 역학
특허 분석
줄기세포 시장 규모 : 제품별 및 CAGR(2024-2031년)
시장 개요
성체줄기세포(ASC)
조혈
간엽계
뉴럴
상피/피부
기타
인간 배아줄기세포(HESC)
유도만능줄기세포(IPSC)
아주 작은 배아 유사 줄기세포
줄기세포 시장 규모 : 용도별 및 CAGR(2024-2031년)
시장 개요
재생의료
신경학
정형외과
종양학
혈액학
심혈관질환 및 심근경색
부상
당뇨병
간질환
요실금
기타
의약품 발견과 개발
줄기세포 시장 규모 : 기술별 및 CAGR(2024-2031년)
시장 개요
세포 획득
골수 채취
제대혈
혈액성분채집술
세포 생산
치료용 클론
체외수정
세포배양
분리
동결보존
증식 및 계대 배양
줄기세포 시장 규모 : 치료법 및 CAGR(2024-2031년)
시장 개요
자가이식
동종이계
줄기세포 시장 규모 : 최종 용도별 및 CAGR(2024-2031년)
시장 개요
제약·바이오테크놀러지 기업
병원과 세포은행
학술조사기관
줄기세포 시장 규모 및 CAGR(2024-2031년)
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2021-2023년)
주요 기업 개요
Thermo Fisher Scientific, Inc.
STEMCELL Technologies Inc.
Merck KGaA
CellGenix GmbH
PromoCell GmbH
Takara Holdings, Inc.
Lonza
Cellular Engineering Technologies
ATCC
AcceGen
Cell Applications, Inc.
Bio-Techne
Organogenesis
FUJIFILM Cellular Dynamics
Gamida Cell
GE Healthcare
Pluristem Therapeutics
Cynata Therapeutics
Smith+Nephew
Medipost
결론과 추천사항
ksm
영문 목차
영문목차
Global Stem Cell Market size was valued at USD 11.9 billion in 2022 and is poised to grow from USD 13.3 billion in 2023 to USD 31.6 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).
The global stem cell market is poised for substantial growth, propelled by an increase in clinical trials and the adoption of innovative therapies worldwide. The COVID-19 pandemic has heightened interest in stem cell treatments, with promising applications in immunomodulation therapies leading to ongoing studies. Significant investments, exemplified by Cellino Biotech's USD 80 million funding to enhance access to these therapies, underline the potential for commercial advancements. Government initiatives, such as Australia's USD 5.9 million funding for innovative stem cell projects, further support market expansion. However, challenges including high costs and ethical dilemmas persist. Despite these hurdles, the rising demand for regenerative medicine and ongoing research efforts present a promising landscape for growth and opportunities in the stem cell sector, benefitting both businesses and patients.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Stem Cell Market Segmental Analysis
Global Stem Cell Market is segmented by Product, Application, Technology, Therapy, End-Use and Region. Based on Product, the market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells. Based on Application, the market is segmented into Regenerative Medicine, Cardiovascular and Myocardial Infraction, Drug Discovery and Development. Based on Technology, the market is segmented into Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture. Based on Therapy, the market is segmented into Autologous, Allogeneic. Based on End-Use, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Stem Cell Market
One of the primary drivers of the global stem cell market is the escalating incidence of chronic diseases, including cancer, diabetes, and cardiovascular conditions. This rise in health issues is fueling a growing demand for stem cell therapies, which are being explored as effective treatment alternatives. For example, stem cell therapy for knee pain, particularly due to osteoarthritis, has emerged as a promising non-surgical solution. As more patients seek these innovative therapeutic options to combat chronic ailments, the stem cell market is anticipated to experience considerable expansion, highlighting the pivotal role of stem cell treatments in modern medicine.
Restraints in the Global Stem Cell Market
A significant challenge facing the global stem cell market is the elevated cost linked to stem cell therapies, such as transplants, injections, and various treatments. These high expenses act as a barrier to widespread adoption, especially in developing nations where financial resources may be limited. Consequently, numerous patients find themselves unable to afford these advanced treatments, which in turn hinders the overall growth potential of the market. The affordability issue underscores the need for more accessible solutions and pricing models to enhance patient access and foster broader utilization of stem cell therapies.
Market Trends of the Global Stem Cell Market
The global stem cell market is witnessing a significant trend towards personalized medicine, reshaping therapeutic approaches across various medical conditions. The customization of stem cell therapies to cater to individual patient profiles - including genetic makeup and medical histories - is becoming prevalent, particularly in treatments for knee ailments and other disorders. This evolution is propelled by groundbreaking advancements in stem cell research and technology, which are facilitating the creation of tailored treatments that maximize efficacy and improve patient outcomes. As healthcare shifts towards more individualized approaches, the demand for personalized stem cell therapies is expected to escalate, positioning this segment for substantial growth in the market.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Assessment
Regulatory Landscape
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology
Patent Analysis
Global Stem Cell Market Size by Product & CAGR (2024-2031)
Market Overview
Adult Stem Cells (ASCs)
Hematopoietic
Mesenchymal
Neural
Epithelial/Skin
Others
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (IPSCs)
Very Small Embryonic Like Stem Cells
Global Stem Cell Market Size by Application & CAGR (2024-2031)
Market Overview
Regenerative Medicine
Neurology
Orthopaedics
Oncology
Haematology
Cardiovascular and Myocardial Infraction
Injuries
Diabetes
Liver Disorder
Incontinence
Others
Drug Discovery and Development
Global Stem Cell Market Size by Technology & CAGR (2024-2031)
Market Overview
Cell Acquisition
Bone Marrow Harvest
Umbilical Blood Cord
Apheresis
Cell Production
Therapeutic Cloning
In-vitro Fertilization
Cell Culture
Isolation
Cryopreservation
Expansion and Sub-Culture
Global Stem Cell Market Size by Therapy & CAGR (2024-2031)
Market Overview
Autologous
Allogeneic
Global Stem Cell Market Size by End-Use & CAGR (2024-2031)
Market Overview
Pharmaceutical and Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Global Stem Cell Market Size & CAGR (2024-2031)
North America (Product, Application, Technology, Therapy, End-Use)
US
Canada
Europe (Product, Application, Technology, Therapy, End-Use)
